Skip to content
ClinCalc Pro
Menu
Hypoglycaemia Antidote / Endocrine Agent

Glucagon

Brand names: GlucaGen, Baqsimi (nasal powder)

A pancreatic hormone given parenterally as emergency treatment for severe hypoglycaemia, and also used to relax smooth muscle for certain radiological procedures.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

Glucagon stimulates hepatic glycogenolysis and gluconeogenesis to raise blood glucose, an effect that depends on adequate hepatic glycogen stores.

Prescribing in practice

  • The most important safety point is that glucagon is ineffective when hepatic glycogen is depleted (for example in starvation, prolonged hypoglycaemia, chronic alcohol use, or adrenal insufficiency), so oral or intravenous glucose must follow once the patient can swallow or access allows.
  • After recovery, give oral carbohydrate to replenish glycogen and prevent recurrent hypoglycaemia.
  • Use with caution in phaeochromocytoma, insulinoma, and glucagonoma.

Monitoring

Monitor blood glucose and conscious level after administration, ensuring the patient eats carbohydrate once able and is observed for recurrence.

Counselling the patient

  • Family or carers should be trained to recognise severe hypoglycaemia and to give the injection.
  • After it works, eat a carbohydrate snack as soon as you can swallow safely.
  • Always seek follow-up, as nausea and vomiting are common afterwards and low glucose can recur.

Evidence & guidelines

Glucagon is recommended for out-of-hospital treatment of severe hypoglycaemia in people with diabetes by NICE and national diabetes guidance.

Reference: JBDS Hypoglycaemia Guidelines 2018; NICE NG17; Baqsimi SPC (Eli Lilly); Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.